Tüdőrák: vizsgálatok itt: Kína
1144 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleStudy of LY01610 in Patients With Recurrent Small Cell Lung Cancer
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 686
- Run by
- Luye Pharma Group Ltd.
See details and how to joinNCT06128837 - 2. fázisNot yet taking people in KínaMyeloprotection With Trilaciclib in Pan-cancer Population
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 132
- Run by
- Sun Yat-sen University
See details and how to joinNCT06297811 - No phaseTaking peopleEfficacy and Safety of Single-port Surgical Robot System in Thoraic Surgery
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 20
- Run by
- The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06286150 - 3. fázisTaking peopleEffects of Digital Therapeutic in Whole Process Management of Lung Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 70 év
- People
- 900
- Run by
- Sun Yat-sen University
See details and how to joinNCT06230445 - 2. fázisTaking peopleAK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer
- Where
- Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 43
- Run by
- Henan Cancer Hospital
See details and how to joinNCT05377658 - No phaseTaking peopleExploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 377
- Run by
- Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT05965024 - No phaseTaking peopleCharacteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 60 000
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06255197 - 2. fázisTaking peopleNeoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC
- Where
- Jinan
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Shandong Cancer Hospital and Institute
See details and how to joinNCT06241807 - 3. fázisNot yet taking people in KínaA Study Of SY-3505 Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 255
- Run by
- Shouyao Holdings (Beijing) Co. LTD
See details and how to joinNCT06254599 - 3. fázisTaking peopleA Phase IIII Study of AL8326 in Small Cell Lung Cancer
- Where
- Changchun
- Életkor
- 18 év and over
- People
- 243
- Run by
- Advenchen Laboratories Nanjing Ltd.
See details and how to joinNCT06247605 - 1/2. fázisTaking peopleWBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 56
- Run by
- Fudan University
See details and how to joinNCT06243003 - 2. fázisNot yet taking people in KínaAdebrelimab and Concurrent Radiochemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer
- Where
- Wuhan, Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 48
- Run by
- Henan Cancer Hospital
See details and how to joinNCT06236997 - 3. fázisTaking peoplePhase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO)
- Where
- Changsha, Shanghai
- Életkor
- 18 év to 80 év
- People
- 680
- Run by
- TYK Medicines, Inc
See details and how to joinNCT05382728 - No phaseTaking peopleExploring the Frontiers of Neoadjuvant Therapy for Lung Cancer: a Prospective Observational Real-world Study
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 2000
- Run by
- Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT06216782 - 2. fázisTaking peopleNeoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLC
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Sun Yat-sen University
See details and how to joinNCT05011487 - No phaseTaking peopleMRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC
- Where
- Nanjing
- Életkor
- 18 év and over
- People
- 60
- Run by
- Jiangsu Cancer Institute & Hospital
See details and how to joinNCT06198868 - 2. fázisNot yet taking people in KínaGolidocitinib in Combination With Sintilimab for PD-L1 Selected Treatment Locally Advanced or Metastatic Non-Small Cell Lung Cancer(NSCLC)
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 69
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06198907 - No phaseTaking peopleNon-risk Based Lang Cancer Screening With a One-off LDCT
- Where
- Guangzhou
- Életkor
- 40 év to 74 év
- People
- 11 000
- Run by
- The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT04938804 - 2. fázisTaking peopleTo Assess the Efficacy and Safety of Furmonertinib in Patients With Epidermal Growth Factor Receptor 20ins Mutation Positive Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy
- Where
- Chengdu
- Életkor
- 18 év and over
- People
- 20
- Run by
- Juan LI, MD
See details and how to joinNCT06192849 - 2. fázisNot yet taking people in KínaCVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 98
- Run by
- Convalife (Shanghai) Co., Ltd.
See details and how to joinNCT06183736 - 2. fázisNot yet taking people in KínaPerioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 160
- Run by
- Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT06109402 - 3. fázisTaking peopleSublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 390
- Run by
- Fudan University
See details and how to joinNCT06031181 - No phaseTaking peopleCOVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 1224
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT06168032 - No phaseTaking peopleTransbronchial vs Transthoracic Ablation for Early-stage Peripheral Lung Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 110
- Run by
- Hangzhou Broncus Medical Co., Ltd.
See details and how to joinNCT06052098 - 2. fázisTaking peopleA Study of HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 62
- Run by
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT06147570